☆ 4.4 Letter

Extended follow-up of CD4+ T cell recovery kinetics in a large cohort of patients with B-cell lymphoproliferative disease treated with rituximab-bendamustine

HEMATOLOGICAL ONCOLOGY (2021)

Get Full Text
Add to Collection

Journal

HEMATOLOGICAL ONCOLOGY
Volume 39, Issue 1, Pages 137-140

Publisher

WILEY
DOI: 10.1002/hon.2797

Keywords

bendamustine; CD4 lymphopenia; chronic lymphocytic leukemia; non-Hodgkin lymphoma

Categories

Oncology Hematology

Funding

  1. Gilead Sciences
  2. Nottingham Hospitals Charity
  3. AbbVie
  4. Roche

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.